Novo Nordisk says cyberattack stole pseudonymized trial data and limited IT systems
The breach appears narrow on patient identity, but UK Wegovy approval arrives with new phishing risk for patients and HCPs.
By Turki Al-Mutairi·· 4 min
2 briefings · “pharma”
The breach appears narrow on patient identity, but UK Wegovy approval arrives with new phishing risk for patients and HCPs.
A Merck-trained chemist at the University of Michigan is building “conservation chemistry” with AI speedups and lab robotics.